Ontology highlight
ABSTRACT: Background
Deep brain stimulation (DBS) is an essential treatment option for disabling segmental or generalized dystonia. An underlying monogenic etiology is increasingly recognized as an important predictor of DBS outcomes. Moreover, the genetic background of dystonia is continuously expanding, posing new challenges in the tailored counseling of patients regarding advanced therapies.Methods
To improve the quality of available evidence on the efficacy of DBS for treating monogenic dystonia, we conducted a systematic review in accordance with PRISMA guidelines. We applied a rigorous methodology and maximized the amount of information provided by including all patients, regardless of age or applied rating scale.Results
Our findings confirm the high probability of a go
SUBMITTER: Indelicato E
PROVIDER: S-EPMC12809714 | biostudies-literature | 2026 Jan
REPOSITORIES: biostudies-literature